Diligent Investors, LLC Merck & Co., Inc. Transaction History

Diligent Investors, LLC

$369 Million
Q1 2024

A detailed history of Diligent Investors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Diligent Investors, LLC holds 17,832 shares of MRK stock, worth $2.24 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

17,832

Previous 17,829 0.02%

Holding current value

$2.24 Million

Previous $1.94 Million 21.05%

% of portfolio

0.64%

Previous 0.56%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$113.24 - $131.95 $339 - $395	3 Added 0.02%	17,832 $2.35 Million
Q4 2023 Jan 10, 2024	BUY	$100.18 - $109.02 $5,309 - $5,778	53 Added 0.3%	17,829 $1.94 Million
Q3 2023 Nov 03, 2023	SELL	$102.95 - $114.33 $40,871 - $45,389	-397 Reduced 2.18%	17,776 $1.83 Million
Q2 2023 Jul 24, 2023	SELL	$108.61 - $118.38 $40,402 - $44,037	-372 Reduced 2.01%	18,173 $2.1 Million
Q1 2023 May 10, 2023	BUY	$102.94 - $114.86 $514 - $574	5 Added 0.03%	18,545 $1.97 Million

Q4 2022 Jan 20, 2023	BUY	$87.44 - $112.11 $13,640 - $17,489	156 Added 0.85%	18,540 $0
Q3 2022 Oct 14, 2022	BUY	$84.53 - $94.96 $408,533 - $458,941	4,833 Added 35.67%	18,384 $1.58 Million
Q2 2022 Jul 13, 2022	BUY	$83.49 - $94.64 $500 - $567	6 Added 0.04%	13,551 $1.24 Million
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $3,896 - $4,367	-53 Reduced 0.39%	13,545 $1.11 Million
Q4 2021 Jan 21, 2022	SELL	$72.28 - $90.54 $23,346 - $29,244	-323 Reduced 2.32%	13,598 $1.04 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $89,926 - $99,467	-1,279 Reduced 8.41%	13,921 $1.08 Million
Q1 2021 Apr 23, 2021	BUY	$68.86 - $81.11 $57,911 - $68,213	841 Added 5.86%	15,200 $1.17 Million
Q4 2020 Feb 09, 2021	SELL	$71.77 - $79.65 $25,980 - $28,833	-362 Reduced 2.46%	14,359 $1.18 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $292 - $331	4 Added 0.03%	14,721 $1.22 Million
Q2 2020 Jul 09, 2020	SELL	$70.42 - $80.13 $37,745 - $42,949	-536 Reduced 3.51%	14,717 $1.14 Million
Q1 2020 Apr 29, 2020	SELL	$63.36 - $87.82 $143,953 - $199,527	-2,272 Reduced 12.96%	15,253 $1.17 Million
Q4 2019 Jan 13, 2020	BUY	$77.58 - $87.54 $11,792 - $13,306	152 Added 0.87%	17,525 $1.59 Million
Q3 2019 Oct 22, 2019	SELL	$76.08 - $82.93 $22,139 - $24,132	-291 Reduced 1.65%	17,373 $1.46 Million
Q2 2019 Aug 01, 2019	BUY	$69.84 - $81.59 $4,330 - $5,058	62 Added 0.35%	17,664 $1.48 Million
Q1 2019 May 10, 2019	SELL	$69.58 - $79.36 $44,322 - $50,552	-637 Reduced 3.49%	17,602 $1.46 Million
Q4 2018 Jan 17, 2019	SELL	$65.24 - $75.71 $595,510 - $691,080	-9,128 Reduced 33.35%	18,239 $1.39 Million
Q3 2018 Oct 26, 2018	BUY	$57.69 - $67.84 $173 - $203	3 Added 0.01%	27,367 $1.94 Million
Q2 2018 Jul 23, 2018	SELL	$50.83 - $59.72 $33,700 - $39,594	-663 Reduced 2.37%	27,364 $1.66 Million
Q1 2018 Apr 23, 2018	BUY	$50.96 - $59.23 $917 - $1,066	18 Added 0.06%	28,027 $1.53 Million
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $15,486 - $18,492	300 Added 1.08%	28,009 $1.58 Million
Q3 2017 Nov 09, 2017	SELL	$58.67 - $63.13 $42,183 - $45,390	-719 Reduced 2.53%	27,709 $1.77 Million
Q2 2017 Aug 11, 2017	BUY	N/A	28,428	28,428 $1.82 Million

Others Institutions Holding MRK

# of Institutions

3,770

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diligent Investors, LLC with notifications on news.

Account

Diligent Investors, LLC Merck & Co., Inc. Transaction History